Works matching IS 17588340 AND DT 2020 AND VI 12


Results: 168
    1
    2
    3
    4

    PD-L1 expression with respect to driver mutations in non-small cell lung cancer in an Asian population: a large study of 1370 cases in China.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920965840
    By:
    • Li, Caichen;
    • Liu, Jun;
    • Xie, Zhanhong;
    • Zhu, Feng;
    • Cheng, Bo;
    • Liang, Hengrui;
    • Li, Jianfu;
    • Xiong, Shan;
    • Chen, Zisheng;
    • Liu, Zhichao;
    • Zhao, Yi;
    • Ou, Limin;
    • Zhong, Ran;
    • Wang, Wei;
    • Huang, Jun;
    • Sun, Jinyun;
    • Zhang, Chunya;
    • Weng, Landong;
    • He, Jianxing;
    • Liang, Wenhua
    Publication type:
    Article
    5
    6
    7
    9
    10

    Role of androgen receptor expression in early stage ER+/PgR−/HER2– breast cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920958355
    By:
    • Tagliaferri, Barbara;
    • Quaquarini, Erica;
    • Palumbo, Raffaella;
    • Balletti, Emanuela;
    • Presti, Daniele;
    • Malovini, Alberto;
    • Agozzino, Manuela;
    • Teragni, Cristina Maria;
    • Terzoni, Andrea;
    • Bernardo, Antonio;
    • Villani, Laura;
    • Sottotetti, Federico
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    FOLFIRINOX in borderline resectable and locally advanced unresectable pancreatic adenocarcinoma.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920953294
    By:
    • Yoo, Changhoon;
    • Hwang, Inhwan;
    • Song, Tae Jun;
    • Lee, Sang Soo;
    • Jeong, Jae Ho;
    • Park, Do Hyun;
    • Seo, Dong Wan;
    • Lee, Sung Koo;
    • Kim, Myung-Hwan;
    • Byun, Jae Ho;
    • Park, Jin-hong;
    • Hwang, Dae Wook;
    • Song, Ki Byung;
    • Lee, Jae Hoon;
    • Lee, Woohyung;
    • Chang, Heung-Moon;
    • Kim, Kyu-pyo;
    • Kim, Song Cheol;
    • Ryoo, Baek-Yeol
    Publication type:
    Article
    17
    18
    19

    Outcomes of the 2019 novel coronavirus in patients with or without a history of cancer: a multi-centre North London experience.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920956803
    By:
    • Joharatnam-Hogan, Nalinie;
    • Hochhauser, Daniel;
    • Shiu, Kai-Keen;
    • Rush, Hannah;
    • Crolley, Valerie;
    • Wilson, William;
    • Sharma, Anand;
    • Muhammad, Aun;
    • Anwar, Muhammad;
    • Vasdev, Nikhil;
    • Goldstein, Robert;
    • Kantser, Ganna;
    • Saha, Aramita;
    • Raja, Fharat;
    • Bridgewater, John;
    • Khan, Khurum
    Publication type:
    Article
    20

    EGFR/c-Met and mTOR signaling are predictors of survival in non-small cell lung cancer.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920953731
    By:
    • Crees, Zachary D;
    • Shearrow, Caleb;
    • Lin, Leo;
    • Girard, Jennifer;
    • Arasi, Kavin;
    • Bhoraskar, Aayush;
    • Berei, Joseph;
    • Eckburg, Adam;
    • Anderson, Austin D.;
    • Garcia, Christian;
    • Munger, Ariana;
    • Palani, Sunil;
    • Smith, Thomas J;
    • Sreenivassappa, Shylendra B;
    • Vitali, Connie;
    • David, Odile;
    • Puri, Neelu
    Publication type:
    Article
    21
    22
    23
    24

    A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920947969
    By:
    • Simionato, Francesca;
    • Zecchetto, Camilla;
    • Merz, Valeria;
    • Cavaliere, Alessandro;
    • Casalino, Simona;
    • Gaule, Marina;
    • D'Onofrio, Mirko;
    • Malleo, Giuseppe;
    • Landoni, Luca;
    • Esposito, Alessandro;
    • Marchegiani, Giovanni;
    • Casetti, Luca;
    • Tuveri, Massimiliano;
    • Paiella, Salvatore;
    • Scopelliti, Filippo;
    • Giardino, Alessandro;
    • Frigerio, Isabella;
    • Regi, Paolo;
    • Capelli, Paola;
    • Gobbo, Stefano
    Publication type:
    Article
    25

    A phase II study of liposomal irinotecan with 5-fluorouracil, leucovorin and oxaliplatin in patients with resectable pancreatic cancer: the nITRO trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920947969
    By:
    • Simionato, Francesca;
    • Zecchetto, Camilla;
    • Merz, Valeria;
    • Cavaliere, Alessandro;
    • Casalino, Simona;
    • Gaule, Marina;
    • D'Onofrio, Mirko;
    • Malleo, Giuseppe;
    • Landoni, Luca;
    • Esposito, Alessandro;
    • Marchegiani, Giovanni;
    • Casetti, Luca;
    • Tuveri, Massimiliano;
    • Paiella, Salvatore;
    • Scopelliti, Filippo;
    • Giardino, Alessandro;
    • Frigerio, Isabella;
    • Regi, Paolo;
    • Capelli, Paola;
    • Gobbo, Stefano
    Publication type:
    Article
    26
    27
    28
    29

    Microvascular density assessed by CD31 predicts clinical benefit upon bevacizumab treatment in metastatic colorectal cancer: results of the PassionATE study, a translational prospective Phase II study of capecitabine and irinotecan plus bevacizumab followed by capecitabine and oxaliplatin plus bevacizumab or the reverse sequence in patients in mCRC

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920928635
    By:
    • Bianconi, Daniela;
    • Herac, Merima;
    • Posch, Florian;
    • Schmeidl, Margit;
    • Unseld, Matthias;
    • Kieler, Markus;
    • Brettner, Robert;
    • Müllauer, Leonhard;
    • Riedl, Jakob;
    • Gerger, Armin;
    • Scheithauer, Werner;
    • Prager, Gerald
    Publication type:
    Article
    30
    31
    32
    33

    Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920942378
    By:
    • Galvano, Antonio;
    • Peri, Marta;
    • Guarini, Aurelia Ada;
    • Castiglia, Marta;
    • Grassadonia, Antonino;
    • De Tursi, Michele;
    • Irtelli, Luciana;
    • Rizzo, Sergio;
    • Bertani, Alessandro;
    • Gristina, Valerio;
    • Barraco, Nadia;
    • Russo, Antonio;
    • Natoli, Clara;
    • Bazan, Viviana
    Publication type:
    Article
    34
    35

    Randomized phase II study of valproic acid in combination with bevacizumab and oxaliplatin/fluoropyrimidine regimens in patients with RAS -mutated metastatic colorectal cancer: the REVOLUTION study protocol.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920929589
    By:
    • Avallone, Antonio;
    • Piccirillo, Maria Carmela;
    • Di Gennaro, Elena;
    • Romano, Carmela;
    • Calabrese, Filomena;
    • Roca, Maria Serena;
    • Tatangelo, Fabiana;
    • Granata, Vincenza;
    • Cassata, Antonio;
    • Cavalcanti, Ernesta;
    • Maurea, Nicola;
    • Maiolino, Piera;
    • Silvestro, Lucrezia;
    • De Stefano, Alfonso;
    • Giuliani, Francesco;
    • Rosati, Gerardo;
    • Tamburini, Emiliano;
    • Aprea, Pasquale;
    • Vicario, Valeria;
    • Nappi, Anna
    Publication type:
    Article
    36
    37

    Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920946152
    By:
    • Dimitrakopoulos, Foteinos-Ioannis D.;
    • Kourea, Eleni;
    • Nasioulas, George;
    • Papadopoulou, Eirini;
    • Nikolakopoulos, Achilles;
    • Spyropoulou, Despoina;
    • Kottorou, Anastasia;
    • Karatzas, Andreas;
    • Kalofonos, Haralabos P.;
    • Koutras, Angelos
    Publication type:
    Article
    38
    39
    40
    41

    Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920937427
    By:
    • Petracci, Elisabetta;
    • Scarpi, Emanuela;
    • Passardi, Alessandro;
    • Biggeri, Annibale;
    • Milandri, Carlo;
    • Vecchia, Stefano;
    • Gelsomino, Fabio;
    • Tassinari, Davide;
    • Tamberi, Stefano;
    • Bernardini, Ilaria;
    • Accettura, Caterina;
    • Frassineti, Giovanni Luca;
    • Amadori, Dino;
    • Nanni, Oriana
    Publication type:
    Article
    42
    43
    44
    45
    46

    Vibrational spectroscopy of liquid biopsies for prostate cancer diagnosis.

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920918499
    By:
    • Medipally, Dinesh K. R.;
    • Cullen, Daniel;
    • Untereiner, Valérie;
    • Sockalingum, Ganesh D.;
    • Maguire, Adrian;
    • Nguyen, Thi Nguyet Que;
    • Bryant, Jane;
    • Noone, Emma;
    • Bradshaw, Shirley;
    • Finn, Marie;
    • Dunne, Mary;
    • Shannon, Aoife M.;
    • Armstrong, John;
    • Meade, Aidan D.;
    • Lyng, Fiona M
    Publication type:
    Article
    47
    48
    49

    Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results from a phase III randomized clinical trial (MONALEESA-7).

    Published in:
    Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920943065
    By:
    • Harbeck, Nadia;
    • Franke, Fabio;
    • Villanueva-Vazquez, Rafael;
    • Lu, Yen-Shen;
    • Tripathy, Debu;
    • Chow, Louis;
    • Babu, Govind K;
    • Im, Young-Hyuck;
    • Chandiwana, David;
    • Gaur, Anil;
    • Lanoue, Brad;
    • Rodriguez-Lorenc, Karen;
    • Bardia, Aditya
    Publication type:
    Article
    50